| Market Cap | 62Cr 54Cr 50Cr 46Cr 86Cr 5.95TCr 87Cr 596.66Cr 232.8Cr 3TCr 233.71Cr 228.62Cr 9.96TCr | P/E 2027 * |
-9.1x | P/E 2028 * | -21.3x |
|---|---|---|---|---|---|
| Enterprise Value | 60Cr 51Cr 48Cr 44Cr 83Cr 5.69TCr 83Cr 570.98Cr 222.78Cr 2.87TCr 223.65Cr 218.78Cr 9.53TCr | EV / Sales 2027 * |
0.53x | EV / Sales 2028 * | 0.5x |
| Free-Float |
98.49% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript : Tilray, Inc.
| 1 day | +4.86% |
| Manager | Title | Age | Since |
|---|---|---|---|
Irwin Simon
CEO | Chief Executive Officer | 67 | 01/05/2021 |
Carl Merton
DFI | Director of Finance/CFO | 57 | 01/05/2021 |
Roger Savell
ADM | Chief Administrative Officer | 64 | 31/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Irwin Simon
CHM | Chairman | 67 | 01/05/2021 |
David Clanachan
BRD | Director/Board Member | 64 | 30/04/2021 |
John Herhalt
BRD | Director/Board Member | 69 | 01/05/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.86% | -12.79% | - | - | 62Cr | ||
| -0.13% | -6.44% | +60.34% | +114.35% | 1,04700Cr | ||
| +0.85% | -0.81% | +51.29% | +63.71% | 65TCr | ||
| -1.03% | -3.58% | +21.43% | +72.25% | 45TCr | ||
| -0.88% | -4.08% | +36.55% | +36.50% | 35TCr | ||
| -0.34% | -2.68% | +21.49% | +38.13% | 29TCr | ||
| -1.19% | -2.21% | +1.53% | +11.51% | 25TCr | ||
| -1.05% | -1.57% | +50.30% | +67.68% | 23TCr | ||
| -1.06% | -2.47% | -20.06% | -54.18% | 20TCr | ||
| -2.14% | -0.30% | +28.95% | +87.59% | 18TCr | ||
| Average | -0.29% | -2.68% | +27.98% | +48.61% | 40.66TCr | |
| Weighted average by Cap. | -0.59% | -3.46% | +37.85% | +65.88% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 112.28Cr 97Cr 91Cr 83Cr 156Cr 11TCr 156.49Cr 1.08TCr 419.91Cr 5.42TCr 421.55Cr 412.38Cr 18TCr | 117.67Cr 101.4Cr 95Cr 87Cr 163.49Cr 11TCr 164.01Cr 1.13TCr 440.09Cr 5.68TCr 441.81Cr 432.19Cr 19TCr |
| Net income | -6.15Cr -5.3Cr -4.97Cr -4.53Cr -8.54Cr -587.68Cr -8.57Cr -59Cr -23Cr -296.66Cr -23Cr -23Cr -983.67Cr | -2.69Cr -2.31Cr -2.17Cr -1.98Cr -3.73Cr -256.75Cr -3.74Cr -26Cr -10Cr -129.61Cr -10Cr -9.87Cr -429.75Cr |
| Net Debt | -2.68Cr -2.31Cr -2.16Cr -1.98Cr -3.72Cr -256.1Cr -3.73Cr -26Cr -10Cr -129.28Cr -10Cr -9.84Cr -428.66Cr | -3.93Cr -3.39Cr -3.18Cr -2.9Cr -5.46Cr -375.66Cr -5.48Cr -38Cr -15Cr -189.63Cr -15Cr -14Cr -628.79Cr |
Employees
3,595
Sector
Pharmaceuticals
















